References
Jick H, Vessey M. Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol 1978;107:1-7.
Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertensi 1996;9:695-699.
Pahor M, Guralnik JM, Ferrucci L, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996;348:493-497.
Jick H, Jick SS, Derby LE, Vasilakis C, Myers MW, Meier CR. Calcium channel blockers and risk of cancer. Lancet 1997;349:525-528.
Leader S, Mallick R, Briggs NC. Myocardial infarction in newly diagnosed hypertensive Medicaid patients free of coronary heart disease and treated with calcium channel blockers. Am J Med 1997;102:150-157.
Fitzpatrick AL, Daling JR, Furberg CD, Kronmal RA, Weissfeld JL. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997;80: 1438-1447.
Hardell L, Frederickson M, Axelson O. Case-control study on colon cancer regarding previous diseases and drug intake. Int J Oncol 1996;8:439-444.
Jonas M, Goldbourt U, Boyko V, Mandelzweig L, Behar S, Reicher-Reiss H. Nifedipine and cancer mortality: Ten-year follow-up of 2607 patients after acute myocardial infarction. Cardiovasc Drugs Ther 1998;12:177-181.
Olsen JH, Sorensen HT, Friis S, et al. Cancer risk in users of calciumchannel blockers. Hypertension 1997;29:1091-1094.
Rosenberg L, Sowmya R, Palmer JR, et al. Calcium channel blockers and the risk of cancer. JAMA 1998;279:1000-1004.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jick, H. CCBs and Cancer. Cardiovasc Drugs Ther 12, 509–510 (1998). https://doi.org/10.1023/A:1007743612846
Issue Date:
DOI: https://doi.org/10.1023/A:1007743612846